194 related articles for article (PubMed ID: 22706680)
1. The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia.
Uydu HA; Yıldırmış S; Orem C; Calapoglu M; Alver A; Kural B; Orem A
J Membr Biol; 2012 Nov; 245(11):697-705. PubMed ID: 22706680
[TBL] [Abstract][Full Text] [Related]
2. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte fluidity in patients with hyperlipidemia during statins therapy].
Broncel M; Chojnowska-Jezierska J; Koter-Michalak M; Franiak I
Pol Arch Med Wewn; 2005 Jun; 113(6):531-7. PubMed ID: 16454441
[TBL] [Abstract][Full Text] [Related]
5. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
Uyuklu M; Meiselman HJ; Baskurt OK
Clin Hemorheol Microcirc; 2007; 36(1):25-33. PubMed ID: 17211059
[TBL] [Abstract][Full Text] [Related]
6. The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.
Kural BV; Orem C; Uydu HA; Alver A; Orem A
Coron Artery Dis; 2004 Aug; 15(5):277-83. PubMed ID: 15238825
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Combined Ezetimibe/Atorvastatin Therapy vs. Atorvastatin Monotherapy on the Erythrocyte Membrane Structure in Patients with Coronary Artery Disease: A Pilot Study.
Jackowska P; Pytel E; Koter-Michalak M; Olszewska-Banaszczyk M; Legęza A; Broncel M
Adv Clin Exp Med; 2016; 25(3):433-9. PubMed ID: 27629730
[TBL] [Abstract][Full Text] [Related]
8. [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].
Broncel M; Koter-Michalak M; Chojnowska-Jezierska J
Przegl Lek; 2006; 63(9):738-42. PubMed ID: 17479860
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease.
Ishimitsu T; Ohno E; Ueno Y; Onoda S; Nagase A; Ohira T; Nakano N; Satonaka H
Clin Exp Nephrol; 2014 Oct; 18(5):704-10. PubMed ID: 24198051
[TBL] [Abstract][Full Text] [Related]
10. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia.
Zhang WL; Yan WJ; Sun B; Zou ZP
Lipids Health Dis; 2014 Oct; 13():168. PubMed ID: 25361814
[TBL] [Abstract][Full Text] [Related]
12. [Dynamics of microrheologic properties of erythrocytes in patients with arterial hypertension and dyslipidemia treated with atorvastatin].
Medvedev IN; Skoriatina IA
Klin Med (Mosk); 2012; 90(6):42-5. PubMed ID: 22997720
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status.
Nagila A; Permpongpaiboon T; Tantrarongroj S; Porapakkham P; Chinwattana K; Deakin S; Porntadavity S
Pharmacol Rep; 2009; 61(5):892-8. PubMed ID: 19904013
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits.
Aydin S; Uzun H; Sozer V; Altug T
Pharmacol Res; 2009 Apr; 59(4):242-7. PubMed ID: 19429465
[TBL] [Abstract][Full Text] [Related]
15. Effect of atorvastatin and ezetimibe treatment on serum lipid profile and oxidative state in rats fed with a high-cholesterol diet.
Yasim A; Ozbag D; Kilinc M; Ciralik H; Toru H; Gümüşalan Y
Am J Med Sci; 2010 May; 339(5):448-52. PubMed ID: 20224310
[TBL] [Abstract][Full Text] [Related]
16. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
17. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.
Nagassaki S; Herculano RD; Graeff CF; Tanus-Santos JE
Eur J Clin Pharmacol; 2009 Apr; 65(4):385-92. PubMed ID: 19104789
[TBL] [Abstract][Full Text] [Related]
18. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
Murrow JR; Sher S; Ali S; Uphoff I; Patel R; Porkert M; Le NA; Jones D; Quyyumi AA
J Clin Lipidol; 2012; 6(1):42-9. PubMed ID: 22264573
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia.
Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S
Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
